ISRCTN13476586进行中（未招募）未知
A phase IIb, randomised-controlled, two-centre clinical trial (ExaLT) on the efficacy of a home-based exercise and motivational programme in patients before and after liver transplantation
适应症
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
- 入组人数
- 269
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. Adult Patients (aged 18 years or over)
- •2. Patients listed for a cadaveric, primary liver transplantation (LT) at QEUHB or the RFH
- •3. Being an out-patient at the time of baseline trial visit (consent)
排除标准
- •1. Patient listed for Liver Transplant for any of the following reasons:
- •1.1. Super-urgent Liver Transplant (according to the Kings College criteria)
- •1.2. Multi-organ transplantation (e.g. combined liver and kidney transplant)
- •1.3. Live-related donor Liver Transplant
- •1.4. Re-graft Liver Transplant
- •2. Patients with an inability to safely comply with the exercise intervention due to the following conditions:
- •2.1. Severe hepatic encephalopathy (defined as grade 3 or 4; as judged by the principal or nominated co-investigators)
- •2.2. Oxygen-dependent hepato-pulmonary syndrome
- •3. Patients without liver failure, including:
- •3.1. Liver cancer in the absence of cirrhosis
- •3.2. Polycystic liver disease
- •3.3. Rare metabolic/genetic conditions (e.g. glycogen storage disorders)
- •4. Refusal or lacks capacity to give informed consent to participate in the trial, at the point of study visit 1
研究者
相似试验
进行中（未招募）
不适用
A randomized, controlled, two-center phase II. study assessing the efficacy and safety of intravitreal Lucentis injections in patients with clinically significant macular edema secondary to central retinal vein occlusion.Randomizált, kontrollált, két központban végzett, II. fázisú klinikai vizsgálat a vena centralis retinae elzáródása következtében kialakult, klinikailag jelentos makula ödéma kezelésére használt intravitrealis Lucentis injekció hatékonyságának és biztonságosságának értékelésére - BRAVOMacular edema secondary to central retinal vein occlusionMedDRA version: 9.1Level: LLTClassification code 10007972Term: Central retinal vein occlusionEUCTR2008-007175-24-HUniversity of Pécs, Medical School, Department of Ophthalmology
进行中（未招募）
2 期
A clinical trial of 5 mg psilocybin plus psychological support vs 25 mg psilocybin plus psychological support in adults with generalised anxiety disorderGeneralised anxiety disorderMental and Behavioural DisordersISRCTN14487299Incannex Healthcare Limited96
进行中（未招募）
不适用
A phase II randomised, double-blind, multicenter, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of 3 strengths of AD 452 in adult subjects with active rheumatoid arthritis who are currently taking methotrexate. - Efficacy, safety and tolerability of AD 452 in patients wih RAThe purpose of this clinical trial is to evaluate the clinical efficacy, safety and tolerability of three doses of AD 452 in comparison with placebo in the treatment of subjects with active rheumatoid arthritis.MedDRA version: 7.0Level: PTClassification code 10039073EUCTR2005-002421-31-DEArakis Ltd.292
进行中（未招募）
1 期
A randomized, multi-centre, double-blind, phase II clinical trial of dose finding of Montelukast in patients with erosive osteoarthritis of the hands. HOME study.Erosive osteoarthritis of the handsCTIS2023-506137-30-00Farmalider S.A.50
进行中（未招募）
不适用
A phase II randomized, double-blind, multicentre, placebo-controlled, dose-ranging, parallel group study to compare the efficacy, safety and tolerability of 3 strengths of AD 452 in adult subjects with active rheumatoid arthritis who are currently taking methotrexateLevel: PTClassification code 10039073Rheumatoid arthritisEUCTR2005-002421-31-GBArakis Ltd292